These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 24341036)
21. Renal toxicity with sevoflurane: a storm in a teacup? Gentz BA; Malan TP Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127 [TBL] [Abstract][Full Text] [Related]
22. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents. Higuchi H; Adachi Y; Arimura S; Kanno M; Satoh T Anesth Analg; 2000 Aug; 91(2):434-9. PubMed ID: 10910864 [TBL] [Abstract][Full Text] [Related]
23. Compound A uptake and metabolism to mercapturic acids and 3,3,3-trifluoro-2-fluoromethoxypropanoic acid during low-flow sevoflurane anesthesia: biomarkers for exposure, risk assessment, and interspecies comparison. Kharasch ED; Jubert C Anesthesiology; 1999 Nov; 91(5):1267-78. PubMed ID: 10551576 [TBL] [Abstract][Full Text] [Related]
24. [Kidney function in test subjects: published results and clinical relevance]. Frink EJ Anaesthesist; 1998 Nov; 47 Suppl 1():S33-6. PubMed ID: 9893878 [TBL] [Abstract][Full Text] [Related]
25. Compound A, formaldehyde and methanol concentrations during low-flow sevoflurane anaesthesia: comparison of three carbon dioxide absorbers. Marini F; Bellugi I; Gambi D; Pacenti M; Dugheri S; Focardi L; Tulli G Acta Anaesthesiol Scand; 2007 May; 51(5):625-32. PubMed ID: 17430327 [TBL] [Abstract][Full Text] [Related]
26. [The compound A concentration in a low-flow anesthesia circuit using the new CO2 absorbent SPHERASORB]. Obata R; Bito H; Katoh T; Sato S Masui; 2000 May; 49(5):504-8. PubMed ID: 10846381 [TBL] [Abstract][Full Text] [Related]
27. [The effects of prolonged sevoflurane anesthesia on renal function in liver fibrosis rabbits]. Zhang WY; Yang AM; Yin Y; Fang DF; Li Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 42(4):523-6. PubMed ID: 21866640 [TBL] [Abstract][Full Text] [Related]
28. Quantitative determination of vapor-phase compound A in sevoflurane anesthesia using gas chromatography-mass spectrometry. Bouche MP; Van Bocxlaer JF; Rolly G; Versichelen LF; Struys MM; Mortier E; De Leenheer AP Clin Chem; 2001 Feb; 47(2):281-91. PubMed ID: 11159777 [TBL] [Abstract][Full Text] [Related]
29. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A. Muir WW; Gadawski J Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964 [TBL] [Abstract][Full Text] [Related]
30. [Occupational exposure to nitrous oxide and sevoflurane during pediatric anesthesia: evaluation of an anesthetic gas extractor]. Sanabria Carretero P; Rodríguez Pérez E; Jiménez Mateos E; Palomero Rodríguez E; Goldman Tarlousky L; Gilsanz Rodriguez F; García Caballeroa J Rev Esp Anestesiol Reanim; 2006 Dec; 53(10):618-25. PubMed ID: 17302075 [TBL] [Abstract][Full Text] [Related]
31. Effect of enflurane (Ethrane) anesthesia on geriatric patients. Preliminary report. Hävermark KG; Wåhlin A Acta Anaesthesiol Belg; 1974 May; 25(2):220-2. PubMed ID: 4440439 [No Abstract] [Full Text] [Related]
32. Reducing wastage of inhalation anesthetics using real-time decision support to notify of excessive fresh gas flow. Nair BG; Peterson GN; Neradilek MB; Newman SF; Huang EY; Schwid HA Anesthesiology; 2013 Apr; 118(4):874-84. PubMed ID: 23442753 [TBL] [Abstract][Full Text] [Related]
33. Effects of sevoflurane on postoperative liver functions in morbidly obese as compared to the non-obese patients. Al-Ghanem SM; Massad IM; Al-Barazangi B; Al-Mustafa M; Daoud FS; Abu-Ali H Middle East J Anaesthesiol; 2009 Jun; 20(2):207-11. PubMed ID: 19583067 [TBL] [Abstract][Full Text] [Related]
34. [Efficacy of bispectral index monitoring in improving anesthetic management, economics, and use of the operating theater]. Morimoto Y; Oka S; Mii M; Shinjo Y; Yamashita A; Gohara T; Matsumoto M; Sakabe T Masui; 2002 Aug; 51(8):862-8. PubMed ID: 12229134 [TBL] [Abstract][Full Text] [Related]
36. [Serum and urinary inorganic fluoride concentrations with renal and hepatic functions after repeated sevoflurane anesthesia]. Takenami T; Arai M; Matsuzaki S; Anzai K; Ueno T; Hoka S Masui; 2002 Oct; 51(10):1086-93. PubMed ID: 12428311 [TBL] [Abstract][Full Text] [Related]
37. Effects of low-flow sevoflurane anesthesia on renal function in low birth weight infants. Xing N; Wei X; Chang Y; Du Y; Zhang W BMC Anesthesiol; 2015 Jan; 15():6. PubMed ID: 25971310 [TBL] [Abstract][Full Text] [Related]
38. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia]. Förster H; Behne M; Warnken UH; Asskali F; Dudziak R Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964 [TBL] [Abstract][Full Text] [Related]
39. [Inhalation anaesthesia and total intravenous anaesthesia for hepatic resections]. Shiganova AM; Vyzhigina MA; Balaian OV; Golovkin AS; Iur'eva LA Anesteziol Reanimatol; 2013; (3):9-14. PubMed ID: 24340988 [TBL] [Abstract][Full Text] [Related]
40. Emergence times and airway reactions in general laryngeal mask airway anesthesia: study protocol for a randomized controlled trial. Stevanovic A; Rossaint R; Keszei AP; Fritz H; Fröba G; Pühringer F; Coburn M Trials; 2015 Jul; 16():316. PubMed ID: 26210907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]